2/2/2023 6:49:22 AM
Eli Lilly And Co. (LLY) Has Raised Its FY23 EPS Estimate To 8.35 - 8.55 From 8.10 - 8.30
2/2/2023 6:46:19 AM
Lilly Q4 EPS Up 13% To $2.14 On Reported Basis And Down 4% To $2.09 On Non-GAAP Basis
1/24/2023 6:31:25 AM
Lilly Plans To Invest Addl $450 Mln At Manufacturing Site In Research Triangle Park; To Create At Least 100 New Jobs
1/20/2023 9:01:58 AM
Lilly : FDA Accepts SNDA For Jardiance For Adults With Chronic Kidney Disease
12/22/2022 6:02:54 AM
Lilly, ProQR To Expand Licensing And Collaboration Agreement Focused On New Genetic Medicines
12/14/2022 4:16:39 AM
Lilly And EVA Pharma Announce Collaboration To Deliver Sustainable Supply Of Insulin In Africa
12/13/2022 6:46:39 AM
Lilly Expects To Deliver Strong Financial And Operational Performance In 2023
12/12/2022 4:03:03 PM
Eli Lilly And Co. (LLY) Declares $ 1.13 Dividend for Q1 23, Record Date 2/15/2023
12/12/2022 4:01:56 PM
Lilly Declares Quarterly Dividend Of $1.13/share, Payable March 10/ Record Feb. 15
12/7/2022 8:05:23 AM
Lilly : Phase III Trial Meets Primary Endpoint By Demonstrating Reduction In HbA1c With Jardiance